Click for best price
Biopharmaceutical Vaccines Market Size, Share 2023
| Market size in 2022 |
US$ 55.44 billion
|
Forecast Market size by 2029 |
US$ 61.04 billion
|
| Growth Rate |
CAGR of 11.4% |
Number of Pages |
66 Pages |
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccines. This report contains market size and forecasts of Biopharmaceutical and Vaccines in global, including the following market information:
Global top five companies in 2022 (%)
The global Biopharmaceutical and Vaccines market was valued at US$ 55.44 billion in 2022 and is projected to reach US$ 61.04 billion by 2029, at a CAGR of 11.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biopharmaceutical Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical and Vaccines include Novartis, Pfizer, Sanofi, Roche, Abbott, Biogen Idec, Regeneron Pharmaceuticals, Alexion Pharmaceuticals and Johnson and Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceutical and Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical and Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, by Type, 2022 (%)
- Biopharmaceutical
- Vaccine Production
Global Biopharmaceutical and Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, by Application, 2022 (%)
- Pharmaceuticals Industry
- Clinical Diagnosis
- Scientific Research
- Others
Global Biopharmaceutical and Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biopharmaceutical and Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biopharmaceutical and Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Biopharmaceutical and Vaccines revenues share in global market, 2022 (%)
key players include:
- Novartis
- Pfizer
- Sanofi
- Roche
- Abbott
- Biogen Idec
- Regeneron Pharmaceuticals
- Alexion Pharmaceuticals
- Johnson and Johnson
- GlaxoSmithKline
- Merck
- Lonza
- Boehringer Ingelheim
- Rentschler
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biopharmaceutical and Vaccines, market overview.
- Chapter 2: Global Biopharmaceutical and Vaccines market size in revenue.
- Chapter 3: Detailed analysis of Biopharmaceutical and Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biopharmaceutical and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biopharmaceutical and Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 55.44 billion
|
| Forecast Market size by 2029 |
US$ 61.04 billion
|
| Growth Rate |
CAGR of 11.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biopharmaceutical and Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biopharmaceutical and Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biopharmaceutical and Vaccines Overall Market Size
2.1 Global Biopharmaceutical and Vaccines Market Size: 2022 VS 2029
2.2 Global Biopharmaceutical and Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biopharmaceutical and Vaccines Players in Global Market
3.2 Top Global Biopharmaceutical and Vaccines Companies Ranked by Revenue
3.3 Global Biopharmaceutical and Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceutical and Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biopharmaceutical and Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceutical and Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Biopharmaceutical and Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceutical and Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biopharmaceutical and Vaccines Market Size Markets, 2022 & 2029
4.1.2 Biopharmaceutical
4.1.3 Vaccine Production
4.2 By Type - Global Biopharmaceutical and Vaccines Revenue & Forecasts
4.2.1 By Type - Global Biopharmaceutical and Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Biopharmaceutical and Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biopharmaceutical and Vaccines Market Size, 2022 & 2029
5.1.2 Pharmaceuticals Industry
5.1.3 Clinical Diagnosis
5.1.4 Scientific Research
5.1.5 Others
5.2 By Application - Global Biopharmaceutical and Vaccines Revenue & Forecasts
5.2.1 By Application - Global Biopharmaceutical and Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Biopharmaceutical and Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biopharmaceutical and Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Biopharmaceutical and Vaccines Revenue & Forecasts
6.2.1 By Region - Global Biopharmaceutical and Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Biopharmaceutical and Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biopharmaceutical and Vaccines Revenue, 2018-2029
6.3.2 US Biopharmaceutical and Vaccines Market Size, 2018-2029
6.3.3 Canada Biopharmaceutical and Vaccines Market Size, 2018-2029
6.3.4 Mexico Biopharmaceutical and Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biopharmaceutical and Vaccines Revenue, 2018-2029
6.4.2 Germany Biopharmaceutical and Vaccines Market Size, 2018-2029
6.4.3 France Biopharmaceutical and Vaccines Market Size, 2018-2029
6.4.4 U.K. Biopharmaceutical and Vaccines Market Size, 2018-2029
6.4.5 Italy Biopharmaceutical and Vaccines Market Size, 2018-2029
6.4.6 Russia Biopharmaceutical and Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Biopharmaceutical and Vaccines Market Size, 2018-2029
6.4.8 Benelux Biopharmaceutical and Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biopharmaceutical and Vaccines Revenue, 2018-2029
6.5.2 China Biopharmaceutical and Vaccines Market Size, 2018-2029
6.5.3 Japan Biopharmaceutical and Vaccines Market Size, 2018-2029
6.5.4 South Korea Biopharmaceutical and Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Biopharmaceutical and Vaccines Market Size, 2018-2029
6.5.6 India Biopharmaceutical and Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biopharmaceutical and Vaccines Revenue, 2018-2029
6.6.2 Brazil Biopharmaceutical and Vaccines Market Size, 2018-2029
6.6.3 Argentina Biopharmaceutical and Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biopharmaceutical and Vaccines Revenue, 2018-2029
6.7.2 Turkey Biopharmaceutical and Vaccines Market Size, 2018-2029
6.7.3 Israel Biopharmaceutical and Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Biopharmaceutical and Vaccines Market Size, 2018-2029
6.7.5 UAE Biopharmaceutical and Vaccines Market Size, 2018-2029
7 Biopharmaceutical and Vaccines Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Biopharmaceutical and Vaccines Major Product Offerings
7.1.4 Novartis Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Biopharmaceutical and Vaccines Major Product Offerings
7.2.4 Pfizer Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Biopharmaceutical and Vaccines Major Product Offerings
7.3.4 Sanofi Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Biopharmaceutical and Vaccines Major Product Offerings
7.4.4 Roche Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Biopharmaceutical and Vaccines Major Product Offerings
7.5.4 Abbott Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 Biogen Idec
7.6.1 Biogen Idec Company Summary
7.6.2 Biogen Idec Business Overview
7.6.3 Biogen Idec Biopharmaceutical and Vaccines Major Product Offerings
7.6.4 Biogen Idec Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.6.5 Biogen Idec Key News & Latest Developments
7.7 Regeneron Pharmaceuticals
7.7.1 Regeneron Pharmaceuticals Company Summary
7.7.2 Regeneron Pharmaceuticals Business Overview
7.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Major Product Offerings
7.7.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.7.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.8 Alexion Pharmaceuticals
7.8.1 Alexion Pharmaceuticals Company Summary
7.8.2 Alexion Pharmaceuticals Business Overview
7.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Major Product Offerings
7.8.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.8.5 Alexion Pharmaceuticals Key News & Latest Developments
7.9 Johnson and Johnson
7.9.1 Johnson and Johnson Company Summary
7.9.2 Johnson and Johnson Business Overview
7.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Major Product Offerings
7.9.4 Johnson and Johnson Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.9.5 Johnson and Johnson Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Major Product Offerings
7.10.4 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Biopharmaceutical and Vaccines Major Product Offerings
7.11.4 Merck Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 Lonza
7.12.1 Lonza Company Summary
7.12.2 Lonza Business Overview
7.12.3 Lonza Biopharmaceutical and Vaccines Major Product Offerings
7.12.4 Lonza Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.12.5 Lonza Key News & Latest Developments
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Company Summary
7.13.2 Boehringer Ingelheim Business Overview
7.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Major Product Offerings
7.13.4 Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.13.5 Boehringer Ingelheim Key News & Latest Developments
7.14 Rentschler
7.14.1 Rentschler Company Summary
7.14.2 Rentschler Business Overview
7.14.3 Rentschler Biopharmaceutical and Vaccines Major Product Offerings
7.14.4 Rentschler Biopharmaceutical and Vaccines Revenue in Global Market (2018-2023)
7.14.5 Rentschler Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biopharmaceutical and Vaccines Market Opportunities & Trends in Global Market
Table 2. Biopharmaceutical and Vaccines Market Drivers in Global Market
Table 3. Biopharmaceutical and Vaccines Market Restraints in Global Market
Table 4. Key Players of Biopharmaceutical and Vaccines in Global Market
Table 5. Top Biopharmaceutical and Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biopharmaceutical and Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biopharmaceutical and Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biopharmaceutical and Vaccines Product Type
Table 9. List of Global Tier 1 Biopharmaceutical and Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceutical and Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Biopharmaceutical and Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biopharmaceutical and Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Biopharmaceutical and Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biopharmaceutical and Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Biopharmaceutical and Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biopharmaceutical and Vaccines Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Biopharmaceutical and Vaccines Product Offerings
Table 32. Novartis Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Biopharmaceutical and Vaccines Product Offerings
Table 36. Pfizer Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Biopharmaceutical and Vaccines Product Offerings
Table 40. Sanofi Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Biopharmaceutical and Vaccines Product Offerings
Table 44. Roche Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Abbott Company Summary
Table 47. Abbott Biopharmaceutical and Vaccines Product Offerings
Table 48. Abbott Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. Biogen Idec Company Summary
Table 51. Biogen Idec Biopharmaceutical and Vaccines Product Offerings
Table 52. Biogen Idec Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. Biogen Idec Key News & Latest Developments
Table 54. Regeneron Pharmaceuticals Company Summary
Table 55. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Offerings
Table 56. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Regeneron Pharmaceuticals Key News & Latest Developments
Table 58. Alexion Pharmaceuticals Company Summary
Table 59. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Offerings
Table 60. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. Alexion Pharmaceuticals Key News & Latest Developments
Table 62. Johnson and Johnson Company Summary
Table 63. Johnson and Johnson Biopharmaceutical and Vaccines Product Offerings
Table 64. Johnson and Johnson Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. Johnson and Johnson Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Biopharmaceutical and Vaccines Product Offerings
Table 68. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Biopharmaceutical and Vaccines Product Offerings
Table 72. Merck Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Lonza Company Summary
Table 75. Lonza Biopharmaceutical and Vaccines Product Offerings
Table 76. Lonza Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 77. Lonza Key News & Latest Developments
Table 78. Boehringer Ingelheim Company Summary
Table 79. Boehringer Ingelheim Biopharmaceutical and Vaccines Product Offerings
Table 80. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 81. Boehringer Ingelheim Key News & Latest Developments
Table 82. Rentschler Company Summary
Table 83. Rentschler Biopharmaceutical and Vaccines Product Offerings
Table 84. Rentschler Biopharmaceutical and Vaccines Revenue (US$, Mn) & (2018-2023)
Table 85. Rentschler Key News & Latest Developments
List of Figures
Figure 1. Biopharmaceutical and Vaccines Segment by Type in 2022
Figure 2. Biopharmaceutical and Vaccines Segment by Application in 2022
Figure 3. Global Biopharmaceutical and Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biopharmaceutical and Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biopharmaceutical and Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biopharmaceutical and Vaccines Revenue in 2022
Figure 8. By Type - Global Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 9. By Application - Global Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 10. By Type - Global Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 12. By Application - Global Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 14. By Region - Global Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 15. By Country - North America Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 16. US Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 20. Germany Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 21. France Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 28. China Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. India Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 34. Brazil Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Biopharmaceutical and Vaccines Revenue Market Share, 2018-2029
Figure 37. Turkey Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Biopharmaceutical and Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biogen Idec Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Johnson and Johnson Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GlaxoSmithKline Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Lonza Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Boehringer Ingelheim Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Rentschler Biopharmaceutical and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
